GLH 3.85% 13.5¢ global health limited

forecast pe at 6, page-28

  1. 1,196 Posts.
    lightbulb Created with Sketch. 2
    Yeh on an EV/EBITDA forecast ratio, I believe GLH is on the expensive side now, I think initially I had a rush of blood after the profit upgrade.

    Currently GLH forecasting $1.5m EBITDA (seems that EBITDA is translating close to 100% NPAT), maybe the EBITDA figure will be a tad higher.

    But at 47c this is commanding a market cap of $15m

    This means the forecast EV/EBITDA ratio is coming in at 10.

    Its not expensive certainly not cheap and as everyone has pointed out, the NPAT figure does not include full tax rate, or any R&D expensing. Some outfits in the tech sector expense their R&D 100%!!!! And have much better EV/EBITDA ratios than GLH.

    I am back to my original position when GLH was floating around this price before the sell off, so I am down to 1/4 of the largest position I held when it was trading at 30c.

    All this can change subject to 1/2 yearly results or any more contract wins...

    I will be very impressed if GLH can manage a close above 50c.
 
watchlist Created with Sketch. Add GLH (ASX) to my watchlist
(20min delay)
Last
13.5¢
Change
0.005(3.85%)
Mkt cap ! $7.836M
Open High Low Value Volume
13.0¢ 13.5¢ 13.0¢ $6.465K 48.07K

Buyers (Bids)

No. Vol. Price($)
2 39384 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 1585 1
View Market Depth
Last trade - 15.35pm 29/11/2024 (20 minute delay) ?
GLH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.